AGN 191743

Drug Profile

AGN 191743

Latest Information Update: 10 Oct 1995

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Roche Palo Alto LLC
  • Developer Allergan; Roche Palo Alto LLC
  • Class Antipsoriatics; Corticosteroids
  • Mechanism of Action Arachidonic acid inhibitors; Immunosuppressants; Platelet activating factor inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Atopic dermatitis; Psoriasis

Most Recent Events

  • 10 Oct 1995 Discontinued-I for Atopic dermatitis in USA (Topical)
  • 10 Oct 1995 Discontinued-I for Psoriasis in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top